Summary & Overview
HCPCS Level II S0014: Tacrine Hydrochloride, 10 mg
HCPCS Level II code S0014 designates Tacrine hydrochloride, 10 mg, billed for the supply or administration of this specific drug formulation. While Tacrine has historical use in treating cognitive disorders, its representation as a discrete HCPCS Level II code signals billing for the medication itself in outpatient or clinic dispensing settings. Nationally, HCPCS drug codes like S0014 matter because they standardize reporting for drug provision, support payer adjudication, and affect pharmacy and clinic reimbursement workflows.
Key payers included in this overview are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of the clinical context surrounding the medication, the service setting where billing typically occurs, and what elements are commonly associated with HCPCS drug billing lines. The publication highlights benchmarks and coverage considerations where available and summarizes applicable billing components relevant to revenue cycle teams and pharmacy billing staff.
This document does not provide clinical recommendations. It serves as a national-level reference describing the code purpose, expected service line context, and the payer landscape relevant to organizations billing or reimbursing for HCPCS Level II code S0014.
Billing Code Overview
HCPCS Level II code S0014 represents Tacrine hydrochloride, 10 mg, a pharmacologic agent historically used in cognitive disorders. The service type for this code is medication administration / drug supply, reflecting billing for the specified drug formulation. The typical site of service is outpatient or ambulatory infusion/medication dispensing settings, including pharmacies and clinic-based medication administration areas.
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is an older adult diagnosed with mild to moderate Alzheimer disease or another form of dementia being considered for cholinesterase inhibitor therapy. The patient presents for medication initiation or follow-up in an outpatient neurology clinic, memory disorders clinic, or primary care office. The clinician documents cognitive symptoms, baseline mental status, and relevant medical history (hepatic disease, bradycardia, peptic ulcer disease). Baseline labs (liver function tests) and vital signs are reviewed prior to prescribing tacrine hydrochloride. The pharmacy dispenses S0014 as tacrine hydrochloride 10 mg tablets; dosage titration and monitoring for hepatotoxicity and cholinergic side effects are planned. Typical workflow steps: medication reconciliation, informed consent discussion of risks and benefits, baseline liver enzymes and ECG if clinically indicated, prescription entry using S0014 for billing, patient education on adverse effects, and scheduled follow-up for efficacy and safety monitoring.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier — default | Use when no special circumstances apply. |